Cargando…

The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes

OBJECTIVE: Diabetes is a life-long disease that poses a serious threat to safety and health. We aimed to assess the disease burden attributable to diabetes globally and by different subgroups, and to predict future disease burden using statistical models. METHODS: This study was divided into three s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jianran, Hu, Wan, Ye, Shandong, Deng, Datong, Chen, Mingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469163/
https://www.ncbi.nlm.nih.gov/pubmed/37400673
http://dx.doi.org/10.1007/s44197-023-00138-9
_version_ 1785099381503950848
author Sun, Jianran
Hu, Wan
Ye, Shandong
Deng, Datong
Chen, Mingwei
author_facet Sun, Jianran
Hu, Wan
Ye, Shandong
Deng, Datong
Chen, Mingwei
author_sort Sun, Jianran
collection PubMed
description OBJECTIVE: Diabetes is a life-long disease that poses a serious threat to safety and health. We aimed to assess the disease burden attributable to diabetes globally and by different subgroups, and to predict future disease burden using statistical models. METHODS: This study was divided into three stages. Firstly, we evaluated the disease burden attributable to diabetes globally and by different subgroups in 2019. Second, we assessed the trends from 1990 to 2019. We estimated the annual percentage change of disease burden by applying a linear regression model. Finally, the age-period-cohort model was used to predict the disease burden from 2020 to 2044. Sensitivity analysis was performed with time-series models. RESULTS: In 2019, the number of incidence cases of diabetes globally was 22239396 (95% uncertainty interval (UI): 20599519–24058945). The number of prevalence cases was 459875371 (95% UI 423474244–497980624) the number of deaths cases was 1551170 (95% UI 1445555–1650675) and the number of disability-adjusted life years cases was 70880155 (95% UI 59707574–84174005). The disease burden was lower in females than males and increased with age. The disease burden associated with type 2 diabetes mellitus was greater than that with type 1; the burden also varied across different socio-demographic index regions and different countries. The global disease burden of diabetes increased significantly over the past 30 years and will continue to increase in the future. CONCLUSION: The disease burden of diabetes contributed significantly to the global disease burden. It is important to improve treatment and diagnosis to halt the growth in disease burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s44197-023-00138-9.
format Online
Article
Text
id pubmed-10469163
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-104691632023-09-01 The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes Sun, Jianran Hu, Wan Ye, Shandong Deng, Datong Chen, Mingwei J Epidemiol Glob Health Research Article OBJECTIVE: Diabetes is a life-long disease that poses a serious threat to safety and health. We aimed to assess the disease burden attributable to diabetes globally and by different subgroups, and to predict future disease burden using statistical models. METHODS: This study was divided into three stages. Firstly, we evaluated the disease burden attributable to diabetes globally and by different subgroups in 2019. Second, we assessed the trends from 1990 to 2019. We estimated the annual percentage change of disease burden by applying a linear regression model. Finally, the age-period-cohort model was used to predict the disease burden from 2020 to 2044. Sensitivity analysis was performed with time-series models. RESULTS: In 2019, the number of incidence cases of diabetes globally was 22239396 (95% uncertainty interval (UI): 20599519–24058945). The number of prevalence cases was 459875371 (95% UI 423474244–497980624) the number of deaths cases was 1551170 (95% UI 1445555–1650675) and the number of disability-adjusted life years cases was 70880155 (95% UI 59707574–84174005). The disease burden was lower in females than males and increased with age. The disease burden associated with type 2 diabetes mellitus was greater than that with type 1; the burden also varied across different socio-demographic index regions and different countries. The global disease burden of diabetes increased significantly over the past 30 years and will continue to increase in the future. CONCLUSION: The disease burden of diabetes contributed significantly to the global disease burden. It is important to improve treatment and diagnosis to halt the growth in disease burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s44197-023-00138-9. Springer Netherlands 2023-07-03 /pmc/articles/PMC10469163/ /pubmed/37400673 http://dx.doi.org/10.1007/s44197-023-00138-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Sun, Jianran
Hu, Wan
Ye, Shandong
Deng, Datong
Chen, Mingwei
The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes
title The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes
title_full The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes
title_fullStr The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes
title_full_unstemmed The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes
title_short The Description and Prediction of Incidence, Prevalence, Mortality, Disability-Adjusted Life Years Cases, and Corresponding Age-Standardized Rates for Global Diabetes
title_sort description and prediction of incidence, prevalence, mortality, disability-adjusted life years cases, and corresponding age-standardized rates for global diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469163/
https://www.ncbi.nlm.nih.gov/pubmed/37400673
http://dx.doi.org/10.1007/s44197-023-00138-9
work_keys_str_mv AT sunjianran thedescriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT huwan thedescriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT yeshandong thedescriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT dengdatong thedescriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT chenmingwei thedescriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT sunjianran descriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT huwan descriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT yeshandong descriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT dengdatong descriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes
AT chenmingwei descriptionandpredictionofincidenceprevalencemortalitydisabilityadjustedlifeyearscasesandcorrespondingagestandardizedratesforglobaldiabetes